APOLONIA 60-61 (2025)
Clinical evaluation of topical tranexamic acid in aspirin-treated patients undergoing tooth extraction: bleeding control, healing quality, and postoperative complications
Authors: Anita Ismaili Bimbashi, Biljana Evrosimovska, Gordana Apostolova, Edvard Janev, Daniela Veleska Stevkovska, Tatjana Matlioska Kocevska, Spiro Spasovski, Irena Stojanova, Bekim Ademi
DOI: 10.62636/JMAI8692
Keywords: tranexamic acid; antiplatelet therapy; aspirin; tooth extraction; postoperative bleeding; wound healing.
ABSTRACT
Introduction: Dental extractions in patients receiving continuous
antiplatelet therapy presents a clinical challenge
due to the perceived increased risk of postoperative
bleeding. Current evidence suggests that interruption
of antiplatelet agents may expose patients to serious
thromboembolic events without providing significant
reduction in bleeding complications. Tranexamic acid
(TXA), an antifibrinolytic agent, has been proposed
as a safe and effective local hemostatic measure.
However, limited data exist regarding its impact
on postoperative bleeding control, wound healing,
and infection rates among patients who remain on
antiplatelet therapy
Aim: This study aimed to evaluate the
effectiveness of topical TXA (5%) in controlling
bleeding following simple tooth extractions in
patients maintained on aspirin therapy, as well as to
assess postoperative wound healing, pain incidence,
alveolitis occurrence, and local inflammatory
reactions.
Materials and methods: Twenty patients on
continuous aspirin therapy underwent simple dental
extractions. A 5% TXA solution was applied locally
for 30 minutes immediately after extraction. Bleeding
time, postoperative complications, and healing
outcomes were recorded over a 7-day follow-up
period.
Results: All extractions were completed within
an average of 2 minutes and achieved immediate
hemostasis without postoperative bleeding. Twelve
patients reported mild-to-moderate pain within the first
24 hours. Alveolitis occurred in 3 patients, classified
as moderate in severity. Five patients developed
localized inflammation, resolving spontaneously
within 7 days. No systemic complications or bleedingrelated events were observed.
Conclusion: Local application of 5% TXA is a highly
effective hemostatic strategy for simple extractions
in patients maintained on antiplatelet therapy.
Maintaining aspirin therapy does not increase the
risk of postoperative bleeding when TXA is used, and
wound healing outcomes remain favorable. TXA may
serve as a valuable adjunct in optimizing postoperative
recovery and minimizing complications in this patient
population.